CODX vs ORCL · rev $3.9M vs P/E 31, rev $67.36B
Co-Diagnostics, Inc. Common Stock (CODX) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
CODX currently screens at market cap $31.4M. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the CODX and ORCL stock pages for the full models.
Not investment advice.